NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $42.21 -0.49 (-1.14%) As of 11:41 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$40.62▼$43.0050-Day Range$40.04▼$57.5852-Week Range$38.91▼$147.03Volume229,892 shsAverage Volume1.20 million shsMarket Capitalization$1.22 billionP/E Ratio9.38Dividend YieldN/APrice Target$81.84Consensus RatingHold Company Overview Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices. The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreINSP MarketRank™: Inspire Medical Systems scored higher than 85% of companies evaluated by MarketBeat, and ranked 106th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.10, and is based on no strong buy ratings, 5 buy ratings, 12 hold ratings, and 3 sell ratings.Upside PotentialInspire Medical Systems has a consensus price target of $81.84, representing about 94.5% upside from its current price of $42.08.Amount of Analyst CoverageInspire Medical Systems has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth59.34% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 59.34% in the coming year, from $0.91 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 9.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 9.37, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.00.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.12% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 3.11, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 0.39%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. News and Social Media2.4 / 5News SentimentN/A News SentimentInspire Medical Systems has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Inspire Medical Systems this week, compared to 9 articles on an average week.MarketBeat Follows4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have not sold or bought any company stock.Percentage Held by Insiders2.20% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesInspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation SpotlightJune 12 at 8:00 AM | globenewswire.comInspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced SelloffJune 8, 2026 | seekingalpha.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.June 15 at 1:00 AM | Porter & Company (Ad)Contrasting Inspire Medical Systems (NYSE:INSP) and PPJ Enterprise (OTCMKTS:PPJE)June 4, 2026 | americanbankingnews.comAnalyst warns Inspire Medical has a coding, GLP-1 problemMay 28, 2026 | msn.comWhat Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street?May 27, 2026 | insidermonkey.comInspire Medical drops as BofA cuts to Underperform on lack of coding clarityMay 22, 2026 | seekingalpha.comInspire Medical Systems (INSP) price target decreased by 17.14% to 72.73May 15, 2026 | msn.comSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $92.20 at the beginning of 2026. Since then, INSP shares have decreased by 54.4% and is now trading at $42.0840. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) announced its earnings results on Monday, May, 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems's revenue was up 1.6% compared to the same quarter last year. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' Board of Directors authorized a share buyback program on Monday, August 11th 2025, which authorizes the company to repurchase $200,000,000 in shares, according to EventVestor. This means that the company could buy up to 8.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $101 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 6,750,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' top institutional investors include Assenagon Asset Management S.A. (1.81%), Renaissance Technologies LLC (1.63%), ADAR1 Capital Management LLC (1.41%) and Amundi (0.89%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). Company Calendar Last Earnings5/04/2026Today6/15/2026Next Earnings (Estimated)8/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 INSP's financial health is in the Red zone, according to TradeSmith. INSP has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,333Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$81.84 High Price Target$197.00 Low Price Target$39.00 Potential Upside/Downside+94.5%Consensus RatingHold Rating Score (0-4)2.10 Research Coverage20 Analysts Profitability EPS (Trailing Twelve Months)$4.49 Trailing P/E Ratio9.37 Forward P/E Ratio46.25 P/E Growth4.41Net Income$145.42 million Net Margins14.33% Pretax Margin6.99% Return on Equity10.35% Return on Assets8.81% Debt Debt-to-Equity RatioN/A Current Ratio6.34 Quick Ratio4.48 Sales & Book Value Annual Sales$911.98 million Price / Sales1.33 Cash Flow$2.82 per share Price / Cash Flow14.91 Book Value$26.88 per share Price / Book1.57Miscellaneous Outstanding Shares28,810,000Free Float28,179,000Market Cap$1.21 billion OptionableOptionable Beta0.73 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NYSE:INSP) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
